Site Search
410 result(s) found for “ adaptive therapy”
-
CAR T Effective as First-Line Therapy for High-Risk Lymphoma Patients
New three-year data from the phase 2 ZUMA-12 trial finds durable responses
-
FDA Approves 1st CAR T Therapy for Adults with Acute Lymphoblastic Leukemia
Twelve years and two relapses later, Branden Akens says optimism and a clinical trial helped him start his next chapter
-
Moffitt Announces Proton Therapy Treatment Facility as Part of its Ongoing Expansion
A planned addition to the McKinley Campus follows a $15 Million contribution from the Schulze Family Foundation
-
Moffitt Treats First U.S. Patient with Newly FDA-Approved CAR T Therapy
Moffitt Cancer Center has treated the first U.S. adult lymphoma patient with a therapy formerly available only through clinical trials.
-
New CAR T-Cell Therapy Shows Promising Results for Advanced Multiple Myeloma
Early trial results show high success rates and manageable side effects
-
New Clinical Trial Aims to Genomically Personalize Radiation Therapy for Breast Cancer
Moffitt researchers are testing the feasibility of genomically guided radiation therapy to improve outcomes in triple-negative breast cancer patients...
-
Proton Therapy Offers Benefit over Conventional Radiotherapy for Some Types of Cancer
Delivery is more precise and reduces side effects
-
24MA004N CAR-T: CD112R Based Switch Receptors For CAR-T Therapy
FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICEThe Innovation Dedicated to supporting patients every step of the way, with...
-
CAR T Cancer Therapy a ‘Huge Breakthrough’ for Patients with Lymphoma
FDA has approved Yescarta for patients with certain aggressive lymphomas who don’t respond to standard treatment, thousands more like Jeff Backer...
-
Moffitt Study Finds Promising New Combo Therapy for Drug-Resistant Melanoma
Triplet therapy targeting TIM-3 shows potential to overcome checkpoint resistance in preclinical melanoma models